Larotrectinib demonstrates durable efficacy and safety in an expanded dataset of pediatric patients with TRK fusion cancer Meeting Abstract


Authors: Mascarenhas, L.; Albert, C.; Pappo, A.; Geoerger, B.; Doz, F.; Federman, N.; Nagasubramanian, R.; Bielack, S.; Dubois, S.; Morgenstern, D.; Schulte, J.; Shukla, N.; Reeves, J.; De La Cuesta, E.; Dima, L.; Childs, B.; Laetsch, T.; Van Tilburg, C. M.
Abstract Title: Larotrectinib demonstrates durable efficacy and safety in an expanded dataset of pediatric patients with TRK fusion cancer
Meeting Title: 52nd Congress of the International Society of Paediatric Oncology (SIOP)
Journal Title: Pediatric Blood and Cancer
Volume: 67
Issue: Suppl. 4
Meeting Dates: 2020 Oct 14-17
Meeting Location: Virtual
ISSN: 1545-5009
Publisher: Wiley Periodicals, Inc  
Date Published: 2020-12-01
Start Page: S51
Language: English
ACCESSION: WOS:000581769200099
PROVIDER: wos
PUBMED: 33049088
DOI: 10.1002/pbc.28742
Notes: Meeting Abstract: 0103 / #935 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Neerav Shukla
    160 Shukla